Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page adds a new Revision: v3.4.2 and removes an older funding-status notice and Revision: v3.4.1; these are administrative updates that do not alter trial details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:08:14.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding notice and a site revision (v3.4.1); removed the prior revision (v3.4.0); core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:36:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Administrative updates to page metadata and UI elements, including adding a glossary display, and updating revision/version indicators while removing outdated metadata terms. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T04:23:54.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.4, replacing v3.3.3. No study data or key information were modified.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:07.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study status updated to Completed with actual completion dates (Primary Completion and Study Completion on 2025-12-15); the previous 'Active, not recruiting' status was removed.
    Difference
    0.5%
    Check dated 2026-01-07T01:17:02.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Locations section on the page was reorganized to list New Jersey, New York, and Pennsylvania as separate subsections, replacing the prior 'New Jersey Locations', 'New York Locations', and 'Pennsylvania Locations' headings. The HHS Vulnerability Disclosure link was removed from the footer and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T21:44:15.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.